Home Newsfeeds Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $18

Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $18

Baird analyst Eric Coldwell maintains Owens & Minor (NYSE:OMI) with a Neutral and lowers the price target from $23 to $18.

byBenzinga Newsdesk

March 1, 2023

1 minute read

Baird analyst Eric Coldwell maintains Owens & Minor (NYSE:OMI) with a Neutral and lowers the price target from $23 to $18.

Credit Suisse Maintains Neutral on Highwoods Props, Lowers Price Target to $27

By Benzinga Newsdesk

January 24, 8:33 AM

Credit Suisse analyst Omotayo Okusanya maintains Highwoods Props (NYSE:HIW) with a Neutral and lowers the price target from $29 to $27.

HIW

Analyst Ratings

Deep Dive Into Driven Brands Hldgs Stock: Analyst Perspectives (4 Ratings)

By Benzinga Insights

January 16, 9:00 AM

Ratings for Driven Brands Hldgs (NASDAQ:DRVN) were provided by 4 analysts in the past three months, showcasing a…

DRVN

Here’s Why MEI Pharma (MEIP) Stock Is Moving

By Henry Khederian

April 17, 10:42 AM

MEI Pharma (NASDAQ: MEIP) shares are trading lower by roughly 2.54% to $4.68 Monday morning, though rebounding off the session low of $4.30, after the company announced and effected a 1-for-20 reverse stock split.

MEIP

US Stocks Flat Ahead Of Data Deluge — But Analyst Says Investors May Be In For A Surprise As Earnings Pessimism Overdone

By Shanthi Rexaline

January 18, 7:29 AM

U.S. stocks may get off to a nervous start on Wednesday, as apprehensions concerning fourth-quarter earnings and the state of the economy continue to weigh down.

Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $18

Related Posts

Credit Suisse Maintains Neutral on Highwoods Props, Lowers Price Target to $27

Deep Dive Into Driven Brands Hldgs Stock: Analyst Perspectives (4 Ratings)

Here’s Why MEI Pharma (MEIP) Stock Is Moving

US Stocks Flat Ahead Of Data Deluge — But Analyst Says Investors May Be In For A Surprise As Earnings Pessimism Overdone